Deep PIM kinase substrate profiling reveals new rational cotherapeutic strategies for acute myeloid leukemia.

MLA

Joglekar, Tejashree, et al. “Deep PIM Kinase Substrate Profiling Reveals New Rational Cotherapeutic Strategies for Acute Myeloid Leukemia.” Blood Advances, vol. 8, no. 15, Aug. 2024, pp. 3880–92. EBSCOhost, https://doi.org/10.1182/bloodadvances.2022008144.

APA

Joglekar, T., Chin, A., Voskanian-Kordi, A., Baek, S., Raja, A., Rege, A., Huang, W., Kane, M., Laiho, M., Webb, T. R., Fan, X., Rubenstein, M., Bieberich, C. J., & Li, X. (2024). Deep PIM kinase substrate profiling reveals new rational cotherapeutic strategies for acute myeloid leukemia. Blood Advances, 8(15), 3880–3892. https://doi.org/10.1182/bloodadvances.2022008144

Chicago

Joglekar, Tejashree, Alexander Chin, Alin Voskanian-Kordi, Seungchul Baek, Azim Raja, Apurv Rege, Weiliang Huang, et al. 2024. “Deep PIM Kinase Substrate Profiling Reveals New Rational Cotherapeutic Strategies for Acute Myeloid Leukemia.” Blood Advances 8 (15): 3880–92. doi:10.1182/bloodadvances.2022008144.